CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-21 | Patton Stephana Eilene General Counsel | Purchase | +7,500 | $2.58 | $19K | 7,500 |
| 2017-08-21 | MOHANTY ADITYA P. Co-Chief Executive Officer | Purchase | +7,500 | $2.50 | $19K | 89,696 |
| 2017-08-17 | KINGSLEY ALFRED D See Remarks | Returned to the company | −300,000 | $2.81 | $843K | 5,481,555 |
| 2017-07-31 | KINGSLEY ALFRED D See Remarks | Sale | −150,000 | $2.80 | $420K | 5,781,555 |
| 2017-07-31 | BROADWOOD PARTNERS, L.P. Director | Purchase | +150,000 | $2.80 | $420K | 27,269,254 |
| 2017-07-31 | BROADWOOD PARTNERS, L.P. Director | Purchase | +0 | 27,269,254 | ||
| 2017-07-10 | MOHANTY ADITYA P. Co-Chief Executive Officer | Option exercise | +4,687 | 83,958 | ||
| 2017-07-10 | MOHANTY ADITYA P. Co-Chief Executive Officer | Shares withheld for taxes | −1,762 | $3.09 | $5K | 82,196 |
| 2017-07-10 | MOHANTY ADITYA P. Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −4,687 | 51,563 | ||
| 2017-07-10 | WEST MICHAEL D Co-Chief Executive Officer | Option exercise | +1,562 | 881,451 | ||
| 2017-07-10 | WEST MICHAEL D Co-Chief Executive Officer | Shares withheld for taxes | −587 | $3.09 | $2K | 880,864 |
| 2017-07-10 | WEST MICHAEL D Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −1,562 | 17,188 | ||
| 2017-07-01 | KINGSLEY ALFRED D See Remarks | Grant or award · Option to Purchase Common Shares | +50,000 | 50,000 | ||
| 2017-07-01 | SCHLACHET DAVID Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2017-07-01 | Russell Angus C. Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2017-07-01 | Mulroy Michael H. Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2017-07-01 | FARRELL STEPHEN C Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2017-07-01 | ANDREWS DEBORAH J Director | Grant or award · Option to Purchase Common Shares | +20,000 | 20,000 | ||
| 2017-07-01 | BRADSHER NEAL C Director | Grant or award · OPTION TO PURCHASE COMMON SHARES | +20,000 | 20,000 | ||
| 2017-06-16 | ANDREWS DEBORAH J Director | Purchase | +2,000 | $2.95 | $6K | 6,000 |
Page 16 of 17 · 322 trades